Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00749489 · ClinicalTrials.gov registry record · Phase 3
Improving Pain and Function in Hip Fracture
A Phase 3 study, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- Phase 3
- Development phase
- 164
- Enrollment target
NCT00749489 is a Phase 3 study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 164 participants.
The verdict
NCT00749489, a Phase 3 study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 164 participants
- Enrollment target
Study Summary
The purpose of this study is to compare two different methods of treating pain after a hip fracture.
Interventions
- PROCEDURE Femoral Nerve Block
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 164 participants |
| Start Date | 2008-11 |
| Est. Completion | 2014-05 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00749489
The ClinicalTrials.gov registry entry for NCT00749489 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 164 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Femoral Nerve Block is the first listed.
NCT00749489 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00749489 about?
NCT00749489 is a clinical study titled "Improving Pain and Function in Hip Fracture". The purpose of this study is to compare two different methods of treating pain after a hip fracture.
What is the current status of trial NCT00749489?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 164 participants. The study started on 2008-11. Estimated completion is 2014-05.
What interventions are being tested in trial NCT00749489?
The interventions under investigation include: Femoral Nerve Block (PROCEDURE).
Who is sponsoring clinical trial NCT00749489?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.